Although photodynamic therapy (PDT) is an established modality for cancer treatment, current dosimetric quantities, such as light fluence and PDT dose, do not account for the differences in PDT oxygen consumption for different fluence rates (ϕ). A macroscopic model was adopted to calculate 
INTRODUCTION
Photodynamic therapy (PDT) is currently undergoing intensive clinical investigations as an adjuvant treatment for proliferative disorders including cancer. [1] [2] [3] PDT involves the administration of a photosensitizer, which preferentially accumulates in diseased cells, followed by light excitation at a specific wavelength. 3, 4 。PDT is dynamic and multifaceted with the interactions between a treatment light at a particular wavelength, a photosensitizer, and tissue oxygenation ([ 3 O2]). 2 At Photofrin-PDT, the photosensitizer undergoes mostly type II processes upon photoexcitation in which the triplet state transfers energy to 3 O2 to produce singlet oxygen (ROS).
Generation of reactive 1 O2 ([ROS]rx)
causes cytotoxicity and eventually cell death and/or therapeutic effects 6 .
The results of our study using additional real-time measurements of Photofrin concentration and [ 3 O2] result in reduced uncertainties for correlations between cure index at 14 days and the measured reactive oxygen species, [ROS]rx,mea.
MATERIALS AND METHODS

Tumor Model and PDT Treatment Conditions
Radiation-induced fibrosarcomas (RIF) cells were cultured and injected in the right shoulder regions of 6-8 weeks old female C3H mice (NCI-Frederick, Frederick, MD). 30 μl were injected at a concentration of 1×10 7 cells/ml, as described previously. [8] [9] [10] [11] Animals were under the care of the University of Pennsylvania Laboratory Animal Resources. All studies were approved by the University of Pennsylvania Institutional Animal Care and Use Committee. The fur of the treatment region was clipped prior to cell inoculation, and the treatment area was depilated with Nair (Church & Dwight Co., Inc., Ewing, NJ) at least 24 hours prior to measurements and treatment. Tumors were treated when they were 3~5 mm in diameter. Mice were given a chlorophyll-free (alfalfa-free) rodent diet (Harlan laboratories Inc., Indianapolis, IN) at least 10 days prior to treatment to eliminate the fluorescence signal from chlorophyll-breakdown products, which have a similar range to the photosensitizer spectra obtained in this study. The photosensitizer fluorescence was used to determine the in vivo concentrations in this study, using methods described previously. [7] [8] [9] Treatment delivery was done using an optical fiber with a microlens attachment coupled to a diode laser with the appropriate wavelength for each photosensitizer. A 630 nm laser (Biolitec, Inc., East Longmeadow, MA, USA) was used for Photofrin after a 18~24 hours drug-light interval. The in-air fluence rate (ϕair) is defined as the calculated irradiance determined by the laser power divided by the treatment area (1 cm diameter spot size). The in-air fluence was calculated by multiplying the in-air fluence rate by the treatment time. RIF tumor-bearing mice with no photosensitizer and no light excitation were used as controls (n = 5). Treatment conditions are summarized in Table 1 .
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Photodynamic Therapy Protocol
Photofrin (Pinnacle Biologics, Chicago, Illinois) at a dosage of 5 mg∕kg was injected through the mouse tail vein as described previously. 12, 13 At a 24-h drug-light interval, superficial irradiation of the tumor was performed with a 630-nm laser (Biolitec AG., A-1030, Vienna). A microlens fiber was coupled to the laser to irradiate the tumor uniformly. Animals were assigned to four light dose groups, and each group was comprised of 2 to 3 subgroups with different ϕ. There were a total of 5 treatment 
Photofrin Concentration
Following the drug-light interval of 18~24 hours, measurements of light fluence rate, photosensitizer concentration and [O2] were performed. Photofrin fluorescence spectra was obtained using a custommade multi-fiber contact probe before and after PDT. 
Oxygen Measurements
The in vivo tissue oxygen partial pressure pO2 was measured during PDT treatment using a 
where k is the tumor regrowth factor for each group and kctr is the regrowth factor for the control group, which consisted of tumors to neither Photofrin nor light illumination.
Reactive Oxygen Species Explicit Dosimetry
Type II PDT process can be described by a set of kinetic equations which can be simplified to describe the creation of [ROS]rx 18, 19 . These equations are dependent on the temporal and spatial distribution of
, oxygen supply rate (g), and the photosensitizer-specific reaction-rate parameters (δ, β, σ, and ξ). The relevant equations are:
where ϕ is the light fluence rate, S is the source term, μa and μs' are the absorption and reduced scattering coefficients, respectively. The five parameters involved in the kinetic equations are photosensitizer-specific and details of each can be found elsewhere. 18 
RESULTS AND DISCUSSION
Photofrin-mediated PDT with various in-air fluences, ϕair, and exposure times were performed in mouse models bearing RIF tumors. Tissue optical properties, photosensitizer concentration, and tissue oxygenation were measured to PDT dose, and [ROS]rx. Table 1 summarizes all of the treatment conditions, as well as the measured and calculated quantities using the photochemical parameters summarized in Table 2 . Figure 3 . Figure 3(a) shows that, while fluence correlates sigmoidal with the PDT outcome, it exhibits large uncertainties as defined by the large bounds of the gray area, as well as by the low value of R 2 =0.777. As shown in Figure 3( The PDT dose threshold (439 mM J/cm 2 ) due obtain in this study is comparable to results published studies in literature 306 mM J/cm 2 in in-vitro condition 20, 21 . But it is substantially smaller than that obtain from our previous study(1200 mM J/cm 2 ) 22 . The reason for this different is because the tumor size in the current study is substantially smaller and less variable them the previous study (100 cc vs. 400 cc). This also explain why the relationship between CI. vs. ϕ or CI. vs. PDT dose a sigmoid shape in the current study while no threshold dose behave was observed in the previous.
CONCLUSION
The response of mouse RIF tumors to PDT depends on tissue oxygenation, photosensitizer uptake, total energy delivered, and the ϕ at which treatment is delivered. use these values in conjunction with our model. This study validated the model and photochemical parameters for Photofrin-mediated PDT for an endpoint that is clinically relevant. This is being reported for the first time.
